Amanda Eiden is a Director in Merck's Center for Observational and Real-World Evidence. She conducts research activities to support vaccination for all vaccines and age groups; topics include broad impacts of vaccination, valuation of vaccines, and vaccines confidence. At Merck she has also worked in Global Market Access on the pneumococcal program and Global Policy on the pipeline vaccines.
Prior to joining Merck, Amanda’s professional and academic experiences broadly spanned public health and research, with work designed to advance policies and best practices in the United States, Thailand, and Panama. Some notable experiences include leading infectious disease investigations at the Florida State Health Department - Epidemiology, and academic research focused on reducing vector borne disease and overall pest-related public health impacts.
Amanda holds a PhD from the University of Florida, an MPH from the University of South Florida.
Amanda Eiden is a Director in Merck's Center for Observational and Real-World Evidence. She conducts research activities to support vaccination for all vaccines and age groups; topics include broad impacts of vaccination, valuation of vaccines, and vaccines confidence. At Merck she has also worked in Global Market Access on the pneumococcal program and Global Policy on the pipeline vaccines.
Prior to joining Merck, Amanda’s professional and academic experiences broadly spanned public health and research, with work designed to advance policies and best practices in the United States, Thailand, and Panama. Some notable experiences include leading infectious disease investigations at the Florida State Health Department - Epidemiology, and academic research focused on reducing vector borne disease and overall pest-related public health impacts.
Amanda holds a PhD from the University of Florida, an MPH from the University of South Florida.